Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GE Healthcare Seeks Spectrum For Wireless Patient Monitoring Networks

This article was originally published in The Gray Sheet

Executive Summary

GE Healthcare is battling aerospace interests to gain access to 40 megahertz of government-regulated radiofrequency spectrum to support its plans for new wireless patient monitoring systems

You may also be interested in...



FCC Chairman Sings MBAN Praises In Advance Of May 24 Spectrum Vote

Julius Genachowski, chairman of the Federal Communications Commission, met May 17 with officials from GE Healthcare, Philips Healthcare and George Washington University Hospital to highlight the benefits of medical body area networks in improving care and reducing costs.

Industry Meets With FCC On Medical Body Area Network Spectrum Proposal

Two medtech giants took a step closer to creating a new wireless patient monitoring category called medical body area networks – or MBANs – after negotiating how they might peacefully share a band of radiofrequency spectrum with the aerospace industry.

Industry Meets With FCC On Medical Body Area Network Spectrum Proposal

Two medtech giants took a step closer to creating a new wireless patient monitoring category called medical body area networks – or MBANs – after negotiating how they might peacefully share a band of radiofrequency spectrum with the aerospace industry.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027905

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel